AKUMS DRUGS AND PHARMA L (AKUMS)

NSE: ₹555.50
BSE: ₹556.10
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 1,019.11 1,033.09 1,010.41 1,055.55 1,024.03 1,017.53 1,159.59 1,157.87
YOY Revenue Growth % - - - - 0.48% -1.51% 14.76% 9.69%
Other Income 6.55 13.47 14.56 17.55 26.73 32.37 34.33 35.30
Total Income 1,025.66 1,046.56 1,024.97 1,073.09 1,050.76 1,049.90 1,193.92 1,193.17
Total Expenses + 938.18 958.67 938.70 1,006.17 955.12 984.22 1,076.12 1,070.16
Cost of Materials Consumed 559.50 505.67 564.60 623.85 547.90 552.63 611.26 586.91
Employee Benefit Expense 176.22 180.10 175.60 183.90 176.14 189.27 189.38 199.03
Other Expenses 118.87 135.85 111.06 138.65 137.00 141.22 144.77 146.65
Operating Profit 80.93 74.42 71.71 49.37 68.92 33.31 83.47 87.71
OPM % 7.9% 7.2% 7.1% 4.7% 6.7% 3.3% 7.2% 7.6%
Profit Before Tax + 87.48 91.59 91.05 75.14 95.65 65.67 99.57 121.22
Tax Expense 26.27 24.94 24.74 -74.47 30.96 22.98 31.89 39.87
Tax % 30% 27.2% 27.2% -99.1% 32.4% 35% 32% 32.9%
Profit After Tax 61.21 66.65 66.31 149.61 64.69 42.70 67.67 81.34
EPS (Basic) 4.21 4.37 4.26 9.64 4.15 2.66 4.33 5.53

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025
Revenue from Operations 4,359.02 4,118.16
YOY Revenue Growth % 5.85% -
Other Income 128.73 52.12
Total Income 4,487.74 4,170.28
Total Expenses + 4,085.62 3,841.72
Cost of Materials Consumed 2,298.68 2,253.61
Employee Benefit Expense 753.82 715.82
Other Expenses 569.65 504.42
Operating Profit 273.40 276.43
OPM % 6.3% 6.7%
Profit Before Exceptional 402.13 328.56
Exceptional Items -20.02 16.70
Profit Before Tax + 382.10 345.25
Tax Expense 125.70 1.48
Tax % 32.9% 0.4%
Profit After Tax 256.40 343.78
EPS (Basic) 16.67 22.60

Balance Sheet

Particulars Mar 2026 Mar 2025
ASSETS
Non-Current Assets + 1,887.11 1,838.83
Property, Plant & Equipment 1,448.26 1,390.18
Capital Work in Progress 176.66 159.62
Non-Current Investments 0.14 0.14
Goodwill 2.06 2.06
Other Intangible Assets 5.48 5.13
Current Assets + 3,559.86 2,274.61
Inventories 755.71 680.93
Trade Receivables 796.56 770.30
Cash and Cash Equivalents 386.01 101.19
Current Investments 0.00 0.00
LIABILITIES & EQUITY
Total Equity 3,331.12 3,063.61
Equity Share Capital 30.62 30.62
Other Equity 3,282.73 3,016.39
Non-Current Liabilities 1,021.09 156.08
Current Liabilities 1,094.76 893.75
Total Liabilities 2,115.84 1,049.83

Cash Flow Statement

Particulars Mar 2026 Mar 2025
Cash from Operating Activities 1,181.20 465.20
Cash from Investing Activities -930.27 -547.84
Cash from Financing Activities 33.88 72.79
Net Increase/Decrease in Cash 284.81 -9.86